Literature DB >> 12172914

Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies.

Michael James Stack1, Melanie Jane Chaplin, Jemma Clark.   

Abstract

A panel of ruminant brain tissues were subjected to a Western immunoblotting technique using two monoclonal antibodies (mAbs). The resultant prion protein (PrP) glycoforms showed that three distinctions can be made between natural ovine scrapie cases and sheep experimentally inoculated with bovine spongiform encephalopathy (BSE). Differentiation between BSE-infected cattle and natural cases of sheep scrapie was also possible using these two antibodies. There were subtle differences in the molecular weight positions of the di-glycosylated, mono-glycosylated and unglycosylated forms of the abnormal PrP (PrP(Sc)) associated with these ruminant transmissible spongiform encephalopathies. In particular, a distinct difference for the unglycosylated protein band was observed. For ovine scrapie samples, this band was noticeably of a higher molecular weight than that found for brain samples from the Romney and Cheviot breed sheep infected with BSE and, to a lesser degree, higher than that observed for bovine BSE samples. Using the comparison of glycoform ratios, the technique provided a distinction between the sheep experimentally infected with BSE and natural cases of sheep scrapie but did not provide a distinction between natural cases of bovine BSE and ovine scrapie. The sheep-passaged CH1641 scrapie strain gave molecular weights similar to, but not identical to BSE, and a glycoform ratio similar to ovine scrapie cases. The SSBP1 experimental scrapie strain gave molecular weights that were akin to natural scrapie cases but the glycoform ratio was different to that found for all the other samples. When mAb P4 was substituted for mAb 6H4 in the technique, only the natural scrapie samples and SSBP1 gave strong signals. BSE in sheep and the CH1641 strain gave weak reactions and PrP(Sc) from BSE-infected cattle could not be detected at all. The results suggest that this combination of molecular weight and glycoform ratio analyses, and differentiation with two specific antibodies could be used to provide a possible screening test for BSE in the UK sheep flock, if confirmed as accurate by bioassay and lesion profile analysis in mice inoculated with brain tissue from suspect field cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172914     DOI: 10.1007/s00401-002-0556-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  69 in total

1.  Molecular analysis of cases of Italian sheep scrapie and comparison with cases of bovine spongiform encephalopathy (BSE) and experimental BSE in sheep.

Authors:  Romolo Nonno; Elena Esposito; Gabriele Vaccari; Michela Conte; Stefano Marcon; Michele Di Bari; Ciriaco Ligios; Giovanni Di Guardo; Umberto Agrimi
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Differentiating ovine BSE from CH1641 scrapie by serial protein misfolding cyclic amplification.

Authors:  Maged M Taema; Ben C Maddison; Leigh Thorne; Keith Bishop; Jonathan Owen; Nora Hunter; Claire A Baker; Linda A Terry; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

3.  The first Canadian indigenous case of bovine spongiform encephalopathy (BSE) has molecular characteristics for prion protein that are similar to those of BSE in the United Kingdom but differ from those of chronic wasting disease in captive elk and deer.

Authors:  Michael J Stack; Aru Balachandran; Melanie Chaplin; Linda Davis; Stefanie Czub; Brian Miller
Journal:  Can Vet J       Date:  2004-10       Impact factor: 1.008

Review 4.  The prion strain phenomenon: molecular basis and unprecedented features.

Authors:  Rodrigo Morales; Karim Abid; Claudio Soto
Journal:  Biochim Biophys Acta       Date:  2006-12-15

5.  Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments.

Authors:  Jonathan P Owen; Helen C Rees; Ben C Maddison; Linda A Terry; Leigh Thorne; Roy Jackman; Garry C Whitelam; Kevin C Gough
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

6.  Pathogen-mediated selection in free-ranging elk populations infected by chronic wasting disease.

Authors:  Ryan J Monello; Nathan L Galloway; Jenny G Powers; Sally A Madsen-Bouterse; William H Edwards; Mary E Wood; Katherine I O'Rourke; Margaret A Wild
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

7.  Plasma glucose concentration is maintained during TSE infection of cattle and sheep.

Authors:  R A Horton; G G Allison; D Jayasena; P Rees Stevens; D Clifford; S Everest; R Jackman; J M Moorby
Journal:  Vet Res Commun       Date:  2007-09-06       Impact factor: 2.459

8.  Does the Presence of Scrapie Affect the Ability of Current Statutory Discriminatory Tests To Detect the Presence of Bovine Spongiform Encephalopathy?

Authors:  M M Simmons; M J Chaplin; C M Vickery; S Simon; L Davis; M Denyer; R Lockey; M J Stack; M J O'Connor; K Bishop; K C Gough; B C Maddison; L Thorne; J Spiropoulos
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

9.  Stability of murine scrapie strain 87V after passage in sheep and comparison with the CH1641 ovine strain.

Authors:  Lorenzo González; Francesca Chianini; Nora Hunter; Scott Hamilton; Louise Gibbard; Stuart Martin; Mark P Dagleish; Sílvia Sisó; Samantha L Eaton; Angela Chong; Lynne Algar; Martin Jeffrey
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

10.  Biochemical typing of pathological prion protein in aging cattle with BSE.

Authors:  Seraina Tester; Valerie Juillerat; Marcus G Doherr; Bianca Haase; Miroslaw Polak; Felix Ehrensperger; Tosso Leeb; Andreas Zurbriggen; Torsten Seuberlich
Journal:  Virol J       Date:  2009-05-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.